Prima Nexus / Events / 2017

ELISA Hands-On Workshop

Prima Nexus and the Cell & Molecular Biology Laboratory of the Faculty of Medicine, Universiti Malaya, ran a one-day ELISA hands-on workshop at the Medical Biotechnology Laboratory on 5 April 2017.

· Workshop · Co-organised by Prima Nexus

Group photo of the workshop participants standing in a row in front of the Medical Biotechnology Laboratory banner
Participants of the ELISA hands-on workshop at the Faculty of Medicine, Universiti Malaya, on 5 April 2017.

About the workshop

The workshop was held in the lecture hall and laboratory of the Medical Biotechnology Laboratory (MBL), Faculty of Medicine, Universiti Malaya (UM), in Kuala Lumpur. Its programme covered the principles of ELISA, the preparation of reagents, standards and samples, plate washing, detection, reading the absorbance and analysing the data, with a talk on multiplex immunoassays, which measure several targets in one sample.

The photographs show the participants in lab coats at the laboratory benches, working through the protocol in small groups with the trainers, and a group photo in front of the Medical Biotechnology Laboratory banner.

Prima Nexus’s part

Prima Nexus co-organised the workshop with the Cell & Molecular Biology Laboratory (CMBL) of the Faculty of Medicine. For Prima Nexus’s immunoassay services today, see the ELISA and Luminex page.

More of our work with UM.

About Prima Nexus

Prima Nexus Sdn Bhd is a Malaysian research coordination group founded in 2014. It runs hands-on training for researchers across Malaysia and brings together eight scientific platforms: proteomics (including ELISA and Luminex multiplex immunoassays), genomics, flow cytometry, stem cell research, animal research, clinical trials, bioinformatics, and regulatory and grant support. More about Prima Nexus.

ELISAMultiplex immunoassayData analysis

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.